SCHEMBL21084409

SCHEMBL21084409

CCCC(=O)N1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.82

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.68
CNR2 P34972 1/20 0.68
ALDH1A1 P00352 3/20 0.68
MAPT P10636 5/20 0.66
GFER P55789 1/20 0.66
POLB P06746 3/20 0.66
HPGD P15428 1/20 0.64
HSD17B10 Q99714 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.62
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
TP53 P04637 1/20 0.60
ME2 P23368 1/20 0.59
ME1 P48163 1/20 0.59
ME3 Q16798 1/20 0.59
LMNA P02545 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
USP2 O75604 1/20 0.59
ADAMTS5 Q9UNA0 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4778153 0.87 ALDH1A1 (0.71) CNR1CNR2ALDH1A1MAPTGFER
SCHEMBL28918980 0.86 POLB (0.68) CNR1CNR2ALDH1A1MAPTGFER
SCHEMBL10015690 0.84 ALDH1A1 (0.86) ALDH1A1MAPTGFERPOLBHPGD
SCHEMBL12282092 0.84 MAPT (0.76) ALDH1A1MAPTHSD17B10NPC1RAB9A
SCHEMBL15840437 0.84 GFER (0.61) CNR1CNR2ALDH1A1MAPTGFER
SCHEMBL17208415 0.82 POLB (0.63) CNR1CNR2ALDH1A1MAPTGFER
SCHEMBL6779212 0.82 MAPT (0.63) CNR1CNR2ALDH1A1MAPTPOLB
SCHEMBL8325536 0.82 MAPT (0.68) ALDH1A1MAPTGFERPOLBL3MBTL1
SCHEMBL15840475 0.82 POLB (0.67) CNR1CNR2ALDH1A1MAPTGFER
SCHEMBL6600563 0.81 MAPT (0.62) MAPTLMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110114051-B Antimicrobial compositions 联合利华知识产权控股有限公司 2022-04-08 CN disclosed
EP-3500234-B1 AN ANTIMICROBIAL COMPOSITION UNILEVER NV (NL) 2020-12-16 EP disclosed
US-10617621-B2 Antimicrobial composition CONOPCO, INC. (US) 2020-04-14 US disclosed
US-20190201312-A1 ANTIMICROBIAL COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2019-07-04 US disclosed
US-20190201312-A1 ANTIMICROBIAL COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2019-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190201312-A1 ANTIMICROBIAL COMPOSITION LPO, POLR1C, GPX4 CNR1 4043/4885CNR2 4454/4885ALDH1A1 1228/4885
US-10617621-B2 Antimicrobial composition LPO, POLR1C, GPX4 CNR1 4043/4885CNR2 4454/4885ALDH1A1 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.